42

Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in
Page 2: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Initial Assumptions

• ER assessment• Patient admitted with diagnosis of probable or definite

ACS (UA/NSTEMI)

• Treatment initiated with• O2

• Beta blockers

• Antiplatelet Rx

• Anticoagulant

• Next question• Early invasive

• Conservative (at least initially noninvasive)

Page 3: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Risk Stratification Models

• TIMI Risk Score

• GRACE Risk Model

• FRISC Risk Model

• PURSUIT Risk Score

Page 4: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

TIMI Risk Score

• TIMI 11B

• ESSENCE (Enoxaparin in Non-Q-Wave MI)

• 7081 pts

• Predicts all-cause mortality, new or recurrent MI, or severe recurrent ischemia requiring PCI/CABG within two weeks

• Validated in several studies

Page 5: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Antman EM, et al. JAMA 2000;284:835–42.

Page 6: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

TACTICS Study Validates

Low (0-2) TIMI Risk Score

0

2

4

6

8

10

12

14

16

18

20

Conservative Invasive

%

11.812.8

Cannon CP, et al. N Engl J Med 2001;344:1879–87.

• Death, MI, or Readmission with ACS over 6 months

• 555 TIMI 0-2 patients

• However, in the entire cohort of 2220 patients, early invasive outcomes were better than conservative

Page 7: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

GRACE Risk Model

• Predicts all cause mortality

• Time frame: from discharge to 6 months

• Validated

Page 8: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

>8%High119-263

3-8%Mid89-118

<3%Low1-88

Grace

Score Risk

Prob. Of

Death

GRACE

Risk

Model

Eagle KA, et al. JAMA 2004;291:2727–33.

Page 9: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

59 y/o woman presents to ED

Alice C. SmithA C SHx: After awakening with 20 min of precordial and left arm pressure, dyspnea, diaphoresis; similar episode hours earlier while walking her 16 y/o dachshund.

Risk Factors: Treated HTN

PMH: UGI bleed 2 months ago

Meds: Thiazide, omeprazole

FH: Adopted

Exam: P 90 regular, BP 128/75, S4; otherwise normal

Lab: Initial biomarkers negative; BMP & CBC normal

ECG: ST depression

Page 10: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Ms. Smith’s Admission ECG

Electrocardiogram was normal one year ago

Page 11: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in
Page 12: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

GRACE

Risk Score

80

>8%High119-263

3-8%Mid89-118

<3%Low1-88

Grace

Score Risk

Prob. Of

Death

Page 13: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Early Invasive vs. Conservative Management

in Low-Risk Women in TACTICS Substudy

Glaser R, et al. JAMA 2002;288:3124-9.

• 2220 Patients

• 169 Centers

• 9 Countries

• Follow-up 180 days

Page 14: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

TIMACS:

Results by GRACE Score

Mehta SR, et al. N Engl J Med 2009;360:2165-75.

961 patients

2070 patients

Composite of

Death, MI, or Stroke

Page 15: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Treatment Strategy with Ms. Smith

• Antiplatelet Rx

• Anticoagulants

• Risk factor Rx

• Education

• Assess for development of high risk features as outlined in TIMI and GRACE risk parameters

• Assess LVEF and undertake risk stratification stress testing

Page 16: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Enoxaparin vs UFH in

TIMI 11B and ESSENCE

Antman EM, et al. Eur Heart J 2002;23:308-14.

7081 Patients

Page 17: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Oasis-5

Yusuf S, et al. N Engl J Med 2006;354:1464–76.

Enoxaparin vs Fondaparinux

1152 Patients

Page 18: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

A C SHx: 59 y/o who presents to ED after awakening with 20 min of precordial and left arm pressure, dyspnea, diaphoresis; no prior history of chest discomfort.

Risk Factors: 7 yr H/O type 2 diabetes mellitus, Current smoker (25 pk yrs)

PMH: Otherwise negative

Meds: Metformin

FH: Adopted

Exam: P 90 regular, BP 128/75, S4; otherwise normal

Lab: Initial biomarkers negative; BMP & CBC normal

ECG: T wave abnormality

Page 19: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in
Page 20: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in
Page 21: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

GRACE Score 69

Page 22: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Smokers’ Paradox

• Reduced risk of mortality during an

ACS event

• Younger

• Tendency to develop thrombi on less

severe lesions

• Less severe CAD at presentation

• Tendency to develop thrombi on less

severe lesions

Page 23: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

A C SHx: 59 y/o who presents to ED after awakening with 20 min of precordial and left arm pressure, dyspnea, diaphoresis; similar episode hours earlier while walking her 16 y/o dachshund.

Risk Factors: Treated HTN

PMH: Otherwise negative

Meds: Thiazide, ASA 81 mg QD for several years on advice of next door neighbor

FH: Adopted

Exam: P 90 regular, BP 128/75, S4; otherwise normal

Lab: Initial biomarkers negative; BMP & CBC normal

ECG: ST depression

Page 24: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in
Page 25: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

GRACE Score 80

Page 26: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Aspirin Paradox

• Tend to have more diffuse disease

• Some suggest that these patients

may delay coming in

• Best considered a marker of higher

risk

• Not likely to be due to ASA

resistance

Page 27: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

A C SHx: 59 y/o who presents to ED after awakening with 20 min of precordial and left arm pressure, dyspnea, diaphoresis; no prior history of chest discomfort.

Risk Factors: 7 yr H/O type 2 diabetes mellitus, Current smoker (25 pk yrs)

PMH: Otherwise negative

Meds: Metformin

FH: Adopted

Exam: P 90 regular, BP 128/75, S4; otherwise normal

Lab: Initial TnI 0.11 ng/ml; BMP & CBC normal

ECG: T wave abnormality

Page 28: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in
Page 29: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Grace Score 84

Page 30: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

TACTICS Substudy

19% 29%

17% 12%

Elevated Troponin

Normal Troponin

Invasive Conservative

P = 0.02

Death, MI, or Readmission for ACS

in Women Based on Troponin

Glaser R, et al. JAMA 2002;288:3124-9.

• 2220 Patients

• 169 Centers

• 9 Countries

• Follow-up 180 days

Page 31: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

6 Month Outcomes Based on TnIin TACTICS-TIMI 18

Death or MI

through 6 months

follow-up2220 ACS patients

169 Hospitals

9 Countries

Primary endpoint: Death,

MI, or readmission within

6 months for ACS

Morrow DA, et al. JAMA 2001;286:2405-12.

P = NS

P <0.001

Page 32: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

ICTUS

• 1200 patients

• 42 hospitals in The Netherlands

• All with:• Elevated troponin

• Unstable ischemic Sx

• ECG ischemic change or prior documented CAD

• Randomized to early invasive or to selectively invasive strategy

• Treated with ASA, enoxaparin, and (at time of PCI) abciximab

• 4 years follow-up

de Winter RJ, et al. N Engl J Med 2005;353:1095–104.

Hirsch A, et al. Lancet 2007;369:827–35.

Page 33: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Revascularization procedures

(CABG/PCI) in ICTUS over time

Hirsch A, et al. Lancet 2007;369:827–35.

Page 34: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

ICTUS Study

Hirsch A, et al. Lancet 2007;369:827–35.

Death, MI, or

readmission

with ACS Death

CV DeathDeath or

Spontaneous MI

Page 35: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

FRISC-II

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Cath 1st 7d Revasc 1st

10d

Revasc 1st yrDeath 1st yr MI 1st yr Readmit 1st

yr

Death &/or MI

5yr

Noninvasive

Invasive

P

0.016

P

0.015

P 0.009

Wallentin L, et al. Lancet 2000;356:9–16. Lagerqvist B, et al. J Am Coll

Cardiol 2001;38:41–8. Lagerqvist B, et al. Lancet 2006;368:998–1004.

Sx c/w ACS, &

ECG STT abnormality

or elevated biomarker

2457 Patients

Page 36: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

FRISC-IIProbability of Death or MI Based on Gender

Benefit confined to:

Wallentin L, et al. Lancet 2000;356:9–16. Lagerqvist B, et al. J Am Coll

Cardiol 2001;38:41–8. Lagerqvist B, et al. Lancet 2006;368:998–1004.

• Women: 10/101 (9.9%)

• Men: 4/324 (1.2%)

• P <0.001

Death following CABG:

• Men

• Nonsmokers

• Patients with at least 2 risk factors

Page 37: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

FRISC Score

• Age >70

• Male

• Diabetes mellitus

• Prior myocardial infarction

• ST depression

• Elevated troponin

• Elevated interleukin6 or CRP

Page 38: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

ICTUS Study

Hirsch A, et al. Lancet 2007;369:827–35.

Death or

Spontaneous MI

Page 39: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Conservative Strategy

• O2, Antiplatelet Rx, Beta blockade, Consider ACEI/ARB

• Anticoagulants• UFH

• Enoxaparin

• Fondaparinux

• Treat risk factors

• Educate

• Assess LV function/Risk strat. stress test

• Ongoing risk assessment during follow-up

Page 40: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

2009 Appropriateness Criteria for

Coronary Revascularization

• Evaluated approximately 180 clinical scenarios

• Three specifically address NSTEMI, and identify revascularization as appropriate• Successful culprit vessel PCI during admit

• Recurrent ischemic Sx &/or high-risk stress test after discharge

• Revascularization of add’l artery(s)

• Revascularization of multiple vessels in high risk pt when culprit artery cannot be determined

• Cardiogenic shock• Revascularization of 1 or more arteries

Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009

appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2009;53:530 –53.

Page 41: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

Points to Ponder

• The high risk features are enumerated in these risk models

• Low risk pts can be treated conservatively (or at least with a delayed invasive strategy)

• Women at low risk generally do worse with an invasive strategy

• Consider fondaparinux in pts at increased bleeding risk

• Aspirin paradox

• Smokers’ paradox

Page 42: Initial Assumptions · 11.8 12.8 Cannon CP, et al. N Engl J Med 2001;344:1879–87. • Death, MI, or Readmission with ACS over 6 months • 555 TIMI 0-2 patients • However, in

So how would this noninvasive cardiologist

treat our 4 patients?• Alice

• 2 episodes of pain, ST depression

• HTN

• Recent GI bleed

• TIMI score 2 and GRACE score 80 (both low risk)

• Ann

• 1 episode of pain, T wave abnormality

• Diabetes, tobacco

• TIMI score 0 and GRACE score 69 (both very low risk)

• Alicia

• 2 episodes of pain, ASA, ST depression

• HTN

• TIMI score 3 (intermediate risk) and GRACE score 80 (low risk)

• Aphrodite

• 1 episode of pain, mildly abnormal troponin, T wave abnormality

• Diabetes, tobacco

• TIMI score 1 and GRACE score 84 (both low risk)